Quick Answer
ABVC BIOPHARMA, INC. reported Total Revenue of $509.6 thousand for fiscal year 2024.
ABVC BIOPHARMA, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $509.6K | +234.3% |
| 2023 | $152.4K | -84.3% |
| 2022 | $969.8K | +172.6% |
| 2021 | $355.8K | -26.3% |
| 2020 | $483.0K | -31.2% |
| 2019 | $701.7K | +9988.0% |
| 2018 | $7.0K | +107.0% |
| 2015 | $3.4K | — |
| 2014 | $0.00 | -100.0% |
| 2013 | $7.8K | +36.3% |
| 2012 | $5.7K | +79.1% |
| 2011 | $3.2K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $796.0K | +104.5% | +104.5% |
| September 30, 2024 | $389.3K | +2350.7% | +232.3% |
| June 30, 2024 | $117.1K | +1817.5% | +9621.3% |
| March 31, 2024 | $1.2K | -99.1% | -92.4% |
| September 30, 2023 | $15.9K | -62.4% | +160.0% |
| June 30, 2023 | $6.1K | -98.0% | -95.2% |
| March 31, 2023 | $128.3K | +399.9% | +203.5% |
| September 30, 2022 | $42.3K | -57.3% | -86.5% |
- ABVC BIOPHARMA, INC. showed an increase of +234.3% in Total Revenue compared to the prior fiscal year.
- Over the 2011–2024 period, ABVC BIOPHARMA, INC.’s total revenue has grown by 15874.6% (from $3.2 thousand to $509.6 thousand).
- The most recent figure is from ABVC BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: